Literature DB >> 1974005

Ropinirole without levodopa in Parkinson's disease.

M J Vidailhet, A M Bonnet, S Belal, B Dubois, C Marle, Y Agid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1974005     DOI： 10.1016/0140-6736(90)91855-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

Authors:  C Brefel; C Thalamas; S Rayet; A Lopez-Gil; K Fitzpatrick; S Bullman; D R Citerone; A C Taylor; J L Montastruc; O Rascol
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

2.  Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.

Authors:  A Luzardo-Alvarez; M B Delgado-Charro; J Blanco-Méndez
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

3.  Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism.

Authors:  N R Cutler; S A Reines; L F McLean; J J Sramek; A G Porras; E L Hand
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

4.  Involvement of dopamine D2 receptors in addictive-like behaviour for acetaldehyde.

Authors:  Anna Brancato; Fulvio Plescia; Rosa Anna Maria Marino; Giuseppe Maniaci; Michele Navarra; Carla Cannizzaro
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.